When will Meperidine Hydrochloride Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Meperidine Hydrochloride Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Meperidine Hydrochloride Injection

Brand names: Demerol, Meperidine Hydrochloride

Category: Analgesia/Addiction

Available 6

FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: May 30, 2025 (in shortage 1 year 4 months) · 2 manufacturers, 6 listed presentations

As of Sep 22, 2026, the FDA lists Meperidine Hydrochloride Injection as currently in shortage. Of 6 manufacturer presentations, 6 Available.

Ask your pharmacist: which of the 2 manufacturers below can they order right now, and whether a different strength or form of Meperidine Hydrochloride Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25) NDC 0641-6052-25	Hikma Pharmaceuticals USA, Inc.	Available	Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) NDC 0409-1176-30	Hospira, Inc., a Pfizer Company	Available	-
Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25) NDC 0641-6053-25	Hikma Pharmaceuticals USA, Inc.	Available	Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) NDC 0409-1181-30	Hospira, Inc., a Pfizer Company	Available	-
Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) NDC 0409-1178-30	Hospira, Inc., a Pfizer Company	Available	-
Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) NDC 0641-6054-25	Hikma Pharmaceuticals USA, Inc.	Available	Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Related medications in shortage

Other Analgesia/Addiction medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Meperidine Hydrochloride Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Meperidine Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Meperidine Hydrochloride Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/meperidine-hydrochloride-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).